Menu Search
Equities

Amdocs Ltd

DOX:NSQ

Amdocs Ltd

Actions
TechnologyTechnology
  • Price (USD)85.20
  • Today's Change1.47 / 1.76%
  • Shares traded513.57k
  • 1 Year change+1.96%
  • Beta0.7296
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy5
Outperform3
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 9 analysts offering 12 month price targets for Amdocs Ltd have a median target of 100.00, with a high estimate of 111.00 and a low estimate of 90.00. The median estimate represents a 19.43% increase from the last price of 83.73.
High32.6%111.00
Med19.4%100.00
Low7.5%90.00

Dividends in USD

In 2024, Amdocs Ltd reported a dividend of 1.83 USD. The 4 analysts covering the company expect dividends of 1.76 USD for the upcoming fiscal year, a decrease of 3.72%.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Nov 12, 2024, Amdocs Ltd reported 4th quarter 2024 earnings of 1.70 per share. This result was in line with the consensus of the 7 analysts following the company and exceeded last year's 4th quarter results by 19.72%.
The next earnings announcement is expected on Feb 04, 2025.
Average growth rate+4.66%
Amdocs Ltd reported annual 2024 earnings of 6.44 per share on Nov 12, 2024.
Average growth rate+9.75%
More ▼

Revenue history & estimates in USD

Amdocs Limited had 4th quarter 2024 revenues of 1.26bn. This bettered the 1.26bn consensus of the 7 analysts covering the company. This was 6.59% above the prior year's 4th quarter results.
Average growth rate+0.43%
Amdocs Limited had revenues for the full year 2024 of 5.00bn. This was 2.40% above the prior year's results.
Average growth rate+4.70%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.